BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

979 related articles for article (PubMed ID: 23485365)

  • 21. TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling.
    Martin P; Wagh V; Reis SA; Erdin S; Beauchamp RL; Shaikh G; Talkowski M; Thiele E; Sheridan SD; Haggarty SJ; Ramesh V
    Mol Autism; 2020; 11(1):2. PubMed ID: 31921404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FMRP S499 is phosphorylated independent of mTORC1-S6K1 activity.
    Bartley CM; O'Keefe RA; Bordey A
    PLoS One; 2014; 9(5):e96956. PubMed ID: 24806451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.
    Di Nardo A; Kramvis I; Cho N; Sadowski A; Meikle L; Kwiatkowski DJ; Sahin M
    J Neurosci; 2009 May; 29(18):5926-37. PubMed ID: 19420259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High glucose concentrations mask cellular phenotypes in a stem cell model of tuberous sclerosis complex.
    Rocktäschel P; Sen A; Cader MZ
    Epilepsy Behav; 2019 Dec; 101(Pt B):106581. PubMed ID: 31761686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microglial activation during epileptogenesis in a mouse model of tuberous sclerosis complex.
    Zhang B; Zou J; Han L; Rensing N; Wong M
    Epilepsia; 2016 Aug; 57(8):1317-25. PubMed ID: 27263494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis.
    Waltereit R; Welzl H; Dichgans J; Lipp HP; Schmidt WJ; Weller M
    J Neurochem; 2006 Jan; 96(2):407-13. PubMed ID: 16300636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberous sclerosis as an underlying basis for infantile spasm.
    Yeung RS
    Int Rev Neurobiol; 2002; 49():315-32. PubMed ID: 12040899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes.
    Kútna V; O'Leary VB; Newman E; Hoschl C; Ovsepian SV
    Neurotherapeutics; 2021 Apr; 18(2):845-858. PubMed ID: 33398801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complex Neurological Phenotype in Mutant Mice Lacking Tsc2 in Excitatory Neurons of the Developing Forebrain(123).
    Crowell B; Lee GH; Nikolaeva I; Dal Pozzo V; D'Arcangelo G
    eNeuro; 2015; 2(6):. PubMed ID: 26693177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.
    Ehninger D; Han S; Shilyansky C; Zhou Y; Li W; Kwiatkowski DJ; Ramesh V; Silva AJ
    Nat Med; 2008 Aug; 14(8):843-8. PubMed ID: 18568033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex.
    Rensing N; Han L; Wong M
    Epilepsia; 2015 Jul; 56(7):1088-97. PubMed ID: 26122303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolated cortical tuber in an infant with genetically confirmed tuberous sclerosis complex 1 presenting with symptomatic West syndrome.
    Miyata H; Fushimi S; Ota Y; Vinters HV; Adachi K; Nanba E; Akiyama T
    Neuropathology; 2021 Feb; 41(1):58-64. PubMed ID: 33181865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple Critical Periods for Rapamycin Treatment to Correct Structural Defects in
    Cox RL; Calderon de Anda F; Mangoubi T; Yoshii A
    Front Mol Neurosci; 2018; 11():409. PubMed ID: 30467464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neural progenitors derived from Tuberous Sclerosis Complex patients exhibit attenuated PI3K/AKT signaling and delayed neuronal differentiation.
    Zucco AJ; Pozzo VD; Afinogenova A; Hart RP; Devinsky O; D'Arcangelo G
    Mol Cell Neurosci; 2018 Oct; 92():149-163. PubMed ID: 30144504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberous sclerosis: a review of the past, present, and future.
    Uysal SP; Şahin M
    Turk J Med Sci; 2020 Nov; 50(SI-2):1665-1676. PubMed ID: 32222129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A brain proteomic investigation of rapamycin effects in the
    Wesseling H; Elgersma Y; Bahn S
    Mol Autism; 2017; 8():41. PubMed ID: 28775826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain Symptoms of Tuberous Sclerosis Complex: Pathogenesis and Treatment.
    Mizuguchi M; Ohsawa M; Kashii H; Sato A
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stochastic model of Tsc1 lesions in mouse brain.
    Prabhakar S; Goto J; Zhang X; Sena-Esteves M; Bronson R; Brockmann J; Gianni D; Wojtkiewicz GR; Chen JW; Stemmer-Rachamimov A; Kwiatkowski DJ; Breakefield XO
    PLoS One; 2013; 8(5):e64224. PubMed ID: 23696872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
    Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
    Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberous sclerosis complex.
    Hasbani DM; Crino PB
    Handb Clin Neurol; 2018; 148():813-822. PubMed ID: 29478616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.